Journal article 963 views
The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme
Andrew Warrilow,
C. M. Hull,
Josie Parker 
,
E. P. Garvey,
W. J. Hoekstra,
W. R. Moore,
R. J. Schotzinger,
Diane Kelly,
Steven Kelly ,
Claire Hull
,
E. P. Garvey,
W. J. Hoekstra,
W. R. Moore,
R. J. Schotzinger,
Diane Kelly,
Steven Kelly ,
Claire Hull
Antimicrobial Agents and Chemotherapy, Volume: 58, Issue: 12, Pages: 7121 - 7127
Swansea University Authors:
Andrew Warrilow, Josie Parker , Diane Kelly, Steven Kelly , Claire Hull
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1128/AAC.03707-14
Abstract
The Clinical Candidate VT-1161 Is a Highly Potent Inhibitor of Candida albicans CYP51 but Fails To Bind the Human Enzyme
| Published in: | Antimicrobial Agents and Chemotherapy |
|---|---|
| Published: |
2014
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa18693 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Item Description: |
E-pub ahead of press. |
|---|---|
| College: |
Swansea University Medical School |
| Issue: |
12 |
| Start Page: |
7121 |
| End Page: |
7127 |